Clinical histone deacetylase inhibitors are effective against COVID-19
COVID-19, caused by the SARS-CoV-2 virus, has posed serious health threats to humanity and jeopardized the global economy.
Dec 14, 2020
0
6
COVID-19, caused by the SARS-CoV-2 virus, has posed serious health threats to humanity and jeopardized the global economy.
Dec 14, 2020
0
6
Each day, at least half a million Danes take a small pill to keep their blood pressure down or to protect against heart disease, and they should continue to take the medicine during the pandemic—even if the pill they take ...
Dec 9, 2020
0
2
Cells in the nasal passages and upper airways are likely the coronavirus' major point of entry into the body, according to a study by Stanford Medicine researchers.
Dec 8, 2020
0
210
(HealthDay)—Two preliminary studies offer mixed news for heart patients who fall ill with COVID-19: Those on certain blood pressure-lowering drugs are not at increased risk of dying, but those with atrial fibrillation (a-fib) ...
Nov 9, 2020
0
5
Fears that people with high blood pressure are more at risk from severe COVID-19 because it is easier for the virus to enter their cells and tissues have been laid to rest, thanks to research by an international team of scientists.
Oct 27, 2020
0
4
Drugs to lower blood pressure, specifically ACE inhibitors or angiotensin II receptor blockers, reduce the mortality rate of influenza and pneumonia.
Oct 2, 2020
0
1
Early in the onset of the COVID-19 pandemic, a small study in China produced results that influenced subsequent research on the virus. Researchers at the University of Cincinnati used the same study parameters on a much larger ...
Sep 17, 2020
0
164
People with Parkinson's disease are more likely than people of a similar age without the disease to have a sudden drop in blood pressure upon standing, a phenomenon called orthostatic hypotension, according to a new study ...
Sep 16, 2020
0
6
Heart patients hospitalized with COVID-19 can safely continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), according to the BRACE CORONA trial presented in a Hot Line session ...
Sep 1, 2020
0
3
Worldwide, 850 million people are affected by chronic kidney disease (CKD)—a worrying figure, and one that continues to rise. Treatment options for patients with CKD are multiple and often determined by the etiology of ...
Aug 31, 2020
0
7